cmAngio® vs Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
cmAngio®
by CureMetrix
VS
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
by Element Science

AI Verdict

Tool A is an AI software designed for detecting breast arterial calcifications on mammograms to assess cardiovascular risk, focusing on diagnostic imaging analysis. In contrast, Tool B is a wearable device with a machine learning algorithm for continuous heart monitoring and direct treatment of life-threatening arrhythmias. While both utilize AI in cardiology, their primary functions are distinct: risk assessment through imaging versus real-time cardiac event management and intervention.

Choose cmAngio® if…

Choose cmAngio® if your objective is to proactively assess cardiovascular risk in women by leveraging existing mammography images. This AI-powered software efficiently detects Breast Arterial Calcifications (BAC) without requiring additional radiation or procedures, providing valuable insights into a patient's cardiovascular health during routine breast cancer screenings. It is ideal for integrating cardiovascular risk stratification into women's health programs.

View cmAngio® →

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose the Jewel Patch Wearable Cardioverter Defibrillator if you require a highly compliant, discreet, and water-resistant solution for continuous heart monitoring and immediate treatment of life-threatening arrhythmias. This patch-based device is designed for patients at risk of sudden cardiac arrest who need active defibrillation therapy outside of a hospital setting, ensuring constant protection and near real-time data for medical teams.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Wearable device with mobile app
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cmAngio®

cmAngiou00ae (Tool A) emphasizes ease of integration into existing clinical workflows with 'quick and easy installation (less than an hour)' and compatibility with 'any DICOM-compliant viewer'. This directly addresses usability for healthcare providers and IT staff. While Jewel (Tool B) highlights high patient compliance, its hardware component and associated apps may introduce more complexity for the healthcare enterprise to manage.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel Patch Wearable Cardioverter Defibrillator (Tool B) offers direct detection and treatment of 'life-threatening arrhythmias', providing immediate life-saving intervention. cmAngiou00ae (Tool A) provides valuable 'insights into cardiovascular health and aiding early risk assessment' by detecting BAC on mammograms, which is a preventative and diagnostic aid, but not a direct therapeutic intervention for an acute, life-threatening condition.

Pricing & Value

Tie

Both tools state 'contact for details' for pricing, indicating a lack of public transparency. While cmAngiou00ae (Tool A) mentions 'limited-time offers for no-cost implementation and service', this is not a permanent offering, making a definitive value comparison impossible without specific pricing information for either product.

Enterprise Readiness

cmAngio®

cmAngiou00ae (Tool A) is a 'Cloud-based' software solution that is 'Cybersecure and HIPAA-compliant' and integrates 'quickly and easily' with existing DICOM viewers, suggesting straightforward enterprise deployment and scalability. Jewel (Tool B), while FDA-cleared and HIPAA-compliant for its data handling, involves a hardware device, mobile application, and cloud platform, which can introduce greater logistical and IT management complexities for an enterprise.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel Patch Wearable Cardioverter Defibrillator (Tool B) demonstrates a higher degree of innovation by combining a 'patch-based wearable' form factor with a 'machine learning detection algorithm' for continuous monitoring and 'treatment of life-threatening arrhythmias'. This represents a significant advancement in discreet, patient-centric therapeutic device technology. cmAngiou00ae (Tool A) innovates by repurposing existing mammography data for new cardiovascular risk insights, but Tool B's direct therapeutic capability in a novel wearable design is more groundbreaking.

Support & Docs

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Element Science (Tool B) provides explicit support resources including 'Product Manuals' (Patient Guide and IFU), 'Instructional Videos' for various aspects of use, and 'Customer Service is available 24 hours a day, 7 days a week' by phone and email. CureMetrix (Tool A) mentions an 'Operator's Manual' and a 'Support' link on its website, but lacks the detailed, explicit, and 24/7 support offerings of Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Product Name cmAngiou00ae Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Company CureMetrix Element Science, Inc.
Primary Use Case FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. A water-resistant, patch-based device with a machine learning algorithm for continuous heart monitoring and treatment of life-threatening arrhythmias, designed for high patient compliance.
Primary Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Target Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology
Core Technology AI software Machine learning algorithm
Key Functionality AI-based detection of Breast Arterial Calcifications (BAC) Detects and treats specific life-threatening arrhythmias

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is a water-resistant, patch-based device with a machine learning algorithm for continuous heart monitoring and treatment of life-threatening arrhythmias.
cmAngiou00ae is AI software that processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams to identify and visualize BAC. The Jewel Patch WCD is a hardware device with a machine learning algorithm that continuously monitors heart rhythm, detects specific life-threatening arrhythmias, and can deliver a defibrillation shock.
cmAngiou00ae analyzes DICOM-compliant mammogram images to provide visualization of BAC location on a scorecard, enabling identification and reporting without additional radiation or procedures. The Jewel Patch WCD continuously monitors heart rhythm and, through its associated Jewel Mobile App, provides near real-time therapy information to the medical team regarding detected and treated arrhythmias.
Patients have no direct interaction with cmAngiou00ae as it is software that analyzes their mammogram images. The Jewel Patch WCD is a wearable, water-resistant patch designed for continuous wear, including showering, with high patient compliance (median wear time over 23 hours/day).
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties due to its focus on BAC detection on mammograms for cardiovascular risk assessment in women. The Jewel Patch WCD is primarily for Cardiology, given its function in monitoring and treating life-threatening arrhythmias.
Both cmAngiou00ae and the Jewel Patch WCD are FDA-cleared. cmAngiou00ae is cybersecure and HIPAA-compliant, while the data handling systems associated with the Jewel P-WCD (e.g., ES Cloud, ES Mobile App) are expected to be HIPAA compliant to protect patient health information.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring cmAngio® or Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.